ATE333907T1 - Fibrinmaterial und verfahren zu seiner herstellung und verwendung - Google Patents
Fibrinmaterial und verfahren zu seiner herstellung und verwendungInfo
- Publication number
- ATE333907T1 ATE333907T1 AT01933275T AT01933275T ATE333907T1 AT E333907 T1 ATE333907 T1 AT E333907T1 AT 01933275 T AT01933275 T AT 01933275T AT 01933275 T AT01933275 T AT 01933275T AT E333907 T1 ATE333907 T1 AT E333907T1
- Authority
- AT
- Austria
- Prior art keywords
- fibrin
- fibrin material
- thrombin
- human
- bioerodible
- Prior art date
Links
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 title abstract 6
- 102000009123 Fibrin Human genes 0.000 title abstract 5
- 108010073385 Fibrin Proteins 0.000 title abstract 5
- 229950003499 fibrin Drugs 0.000 title abstract 5
- 239000000463 material Substances 0.000 title abstract 4
- 108090000190 Thrombin Proteins 0.000 abstract 2
- 229960004072 thrombin Drugs 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- 206010053567 Coagulopathies Diseases 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 230000004888 barrier function Effects 0.000 abstract 1
- 239000012620 biological material Substances 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 230000035602 clotting Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 229940088597 hormone Drugs 0.000 abstract 1
- 239000005556 hormone Substances 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000009885 systemic effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001256 tonic effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01933275A EP1387703B1 (de) | 2001-05-09 | 2001-05-09 | Fibrinmaterial und verfahren zu seiner herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE333907T1 true ATE333907T1 (de) | 2006-08-15 |
Family
ID=36658716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01933275T ATE333907T1 (de) | 2001-05-09 | 2001-05-09 | Fibrinmaterial und verfahren zu seiner herstellung und verwendung |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1695724B1 (de) |
| AT (1) | ATE333907T1 (de) |
| ES (1) | ES2274746T3 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018067622A1 (en) | 2016-10-05 | 2018-04-12 | 3M Innovative Properties Company | Fibrinogen composition, method and wound articles |
| US11827754B2 (en) | 2016-10-05 | 2023-11-28 | 3M Innovative Properties Company | Fibrin composition comprising carrier material, method and wound articles |
| WO2020121290A1 (en) * | 2018-12-12 | 2020-06-18 | Omrix Biopharmaceuticals Ltd. | High concentrated protein compositions for preventing tissue adhesion |
| IL263679A (en) * | 2018-12-12 | 2019-03-31 | Omrix Biopharmaceuticals Ltd | Kits, methods, and compositions for preventing tissue adhesion |
| CN114177346B (zh) * | 2021-12-24 | 2023-05-26 | 中国人民解放军军事科学院军事医学研究院 | 一种止血组合物及止血贴与其应用 |
| CN117110404A (zh) * | 2023-08-24 | 2023-11-24 | 山东大学 | 一种基于纤维蛋白-核酸适配体复合结构的石墨烯场效应晶体管微纳生物传感器及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5318524A (en) * | 1990-01-03 | 1994-06-07 | Cryolife, Inc. | Fibrin sealant delivery kit |
| CA2207992A1 (en) * | 1995-01-16 | 1996-07-25 | Genevieve Krack | Self-supporting sheet-like material of cross-linked fibrin for preventing post operative adhesions |
| WO1998002098A1 (en) * | 1996-07-12 | 1998-01-22 | Baxter International Inc. | A fibrin delivery device and method for forming fibrin on a surface |
| WO1998012274A1 (en) * | 1996-09-23 | 1998-03-26 | Chandrashekar Pathak | Methods and devices for preparing protein concentrates |
| CA2313405A1 (en) * | 1997-12-09 | 1999-06-17 | Bristol-Myers Squibb Company | Fibrinolytic inhibitor for sealant |
-
2001
- 2001-05-09 AT AT01933275T patent/ATE333907T1/de active
- 2001-05-09 EP EP06075900.8A patent/EP1695724B1/de not_active Expired - Lifetime
- 2001-05-09 ES ES06075900.8T patent/ES2274746T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2274746T3 (es) | 2018-04-26 |
| EP1695724A1 (de) | 2006-08-30 |
| EP1695724B1 (de) | 2018-01-24 |
| ES2274746T1 (es) | 2007-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230190995A1 (en) | Controllable self-annealing microgel particles for biomedical applications | |
| Roberts et al. | Fibrin matrices as (injectable) biomaterials: formation, clinical use, and molecular engineering | |
| Guan et al. | Preparation and characterization of a highly macroporous biodegradable composite tissue engineering scaffold | |
| US8728498B2 (en) | Electrospun silk material systems for wound healing | |
| Nakamura et al. | Role of blood coagulation components as intermediators of high osteoconductivity of electrically polarized hydroxyapatite | |
| Meinhart et al. | Enhanced endothelial cell retention on shear-stressed synthetic vascular grafts precoated with RGD-cross-linked fibrin | |
| US20050159820A1 (en) | Member for regenerating joint cartilage and process for producing the same, method of regenerating joint cartilage and artificial cartilage for transplantation | |
| ATE424223T1 (de) | Lokale polymergelzelltherapie | |
| DE50005818D1 (de) | Spritzbares knochenersatzmaterial enthaltend fibrin oder fibrinogen sowie hydroxylapatit zement | |
| NO20002357L (no) | Fibrin-tetningsmidler eller -ad-hesiver inneholdende et hyaluronsyrederivat-materiale | |
| DK1749836T3 (da) | Rekombinant vaskulær endothelcellevækstfaktor D | |
| DE69435096D1 (de) | Zusammensetzung zur in vivo erzeugung von therapeutischen produkten | |
| FI20001696A7 (fi) | Biologisesti aktiivinen materiaali | |
| US20100076465A1 (en) | Fibrin-based nerve repair conduit and method of producing the same | |
| BRPI0813696B1 (pt) | Material de reparo ósseo composto cortável, seu método de preparação e kit | |
| ATE333907T1 (de) | Fibrinmaterial und verfahren zu seiner herstellung und verwendung | |
| DE69921636D1 (de) | Medikamentöse verabreichung von proteinen aus polymergemischen | |
| ES2169681B1 (es) | Metodo de produccion de filmes de quitosan con una alta capacidad de adherencia celular, producto obrenido y aplicaciones. | |
| Murata et al. | Blood permeability of a novel ceramic scaffold for bone morphogenetic protein‐2 | |
| Le Nihouannen et al. | Hybrid composites of calcium phosphate granules, fibrin glue, and bone marrow for skeletal repair | |
| Le Guehennec et al. | Influence of calcium chloride and aprotinin in the in vivo biological performance of a composite combining biphasic calcium phosphate granules and fibrin sealant | |
| KR101472046B1 (ko) | 골 이식재 조성물 및 이의 제조방법 | |
| Wang et al. | Utility of air bladder-derived nanostructured ECM for tissue regeneration | |
| Stahl | Biomaterial-Based Approaches for Vascularization in Bone Tissue Engineering and Regenerative Medicine | |
| JP2004073290A (ja) | 関節軟骨の再生方法およびその再生用部材 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1387703 Country of ref document: EP |